Key Findings:  Data indicates that CBD may exert preventive and protective actions (via activation CB2 and TRPV1 receptor sites) in patient with PD.
Type of Study:  Laboratory Study
Study Result:  Positive
Study Location(s):  Italy
Year of Pub:  2020
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype III
Receptors Studied:  CB2, TRPV1